Overview Request Sample Pages Request Customization Download PDF
You are viewing: Europe Gastrointestinal Stent Market analysis
Part of: Gastrointestinal Stent Market (Global)

The Europe Gastrointestinal Stent Market was valued at $169.7 Million in 2026 and projected to reach to $218.3 Million by 2031, representing a compound annual growth rate of 5.2%. Europe's gastrointestinal stent market is positioned for steady expansion through 2031, supported by an aging demographic profile and increasing prevalence of gastrointestinal disorders across the region.

Europe Gastrointestinal Stent Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Gastrointestinal Stent Market Trends and Insights

  • Europe maintains a mature healthcare infrastructure with strong adoption of minimally invasive endoscopic procedures, driving steady demand for both biliary and esophageal stent solutions.
  • The region benefits from established reimbursement frameworks and high clinical awareness among gastroenterologists, positioning Europe as a significant contributor to global market growth. Driving Europe's market expansion are an aging population with increasing prevalence of gastrointestinal disorders, rising incidence of pancreatic and esophageal cancers, and continuous technological innovations in stent design and delivery systems.
  • Europe's regulatory environment, including CE marking requirements, ensures product quality and safety, further supporting market confidence.
  • Healthcare providers across Europe are increasingly adopting self-expanding metal stents (SEMS) and covered stents for improved clinical outcomes, particularly in palliative care settings..

Key Market Statistics

  • CAGR (2026-2031) 5.2% CAGR
  • Market Size, 2026 ~USD 169.7 Million
  • Forecast, 2031 ~USD 218.3 Million
  • Geography Europe

Europe Gastrointestinal Stent Market Overview

Mature Healthcare Infrastructure :

Europe's well-established healthcare systems and regulatory frameworks support widespread adoption of advanced gastrointestinal stent technologies, ensuring consistent market growth and product innovation across the region.

Strong Minimally Invasive Adoption :

European healthcare providers demonstrate high preference for endoscopic procedures, driving robust demand for both biliary and esophageal stent solutions as alternatives to traditional surgical interventions.

Market Leadership by Germany :

Germany leads Europe's gastrointestinal stent market with USD 53.48 million in market size, reflecting advanced medical device adoption and strong healthcare spending in the region's largest economy.

Steady 5.2% Regional Growth :

Europe's gastrointestinal stent market is projected to grow from USD 169.7 million in 2026 to USD 218.3 million by 2031, demonstrating consistent expansion driven by aging populations and procedural volume increases.

Europe Gastrointestinal Stent Market Dynamics

  • The mature healthcare infrastructure, combined with strong reimbursement policies and high adoption rates of minimally invasive endoscopic procedures, creates a favorable environment for market growth.
  • Key European markets including Germany, UK, and France continue to invest in advanced medical technologies and training programs for gastroenterologists. The region's 5.2% CAGR reflects a balanced market dynamic where established players maintain strong positions while innovation in stent design and biocompatible materials drives incremental growth.
  • Regulatory harmonization through CE marking and increasing awareness of endoscopic treatment benefits among both healthcare providers and patients are expected to sustain demand momentum through 2031..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Europe's gastrointestinal stent market is valued at USD 169.7 million in 2026 and will reach USD 218.3 million by 2031 at a 5.2% CAGR.
    • Europe's mature healthcare infrastructure and established reimbursement systems support consistent adoption of advanced stent technologies.
    • An aging European population and rising incidence of gastrointestinal malignancies are primary growth drivers through 2031.
    • Technological innovations in covered and self-expanding metal stents are reshaping Europe's clinical practice and market dynamics.

    Gastrointestinal Stent Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment BIODEGRADABLE STENTS (Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 5.7% from 2026 to 2031
    Largest Segment HOSPITALS & CLINICS (End User)
    Market Size Base Year (Billions) ~USD 0.62 (2026)
    Revenue Forecast (Billions) ~USD 0.82 (2031)
    Segments Covered Product, Type, Mechanism, Coverage, Application, End User

    Europe Gastrointestinal Stent Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Duodenal Stents
    • Esophageal Stents
    • Metal Stents
    • Pancreatic Stents
    • Plastic Stents

    By Type

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Colorectal Cancer
    • Duodenal Stents
    • Esophageal Cancer
    • Esophageal Stents
    • Magnesium-Based Stents
    • Metal Stents
    • Nitinol Stents
    • Other Biodegradable Stents
    • Other Metal Stents
    • Pancreatic Cancer
    • Pancreatic Stents
    • Plastic Stents
    • Polymer-Based Stents
    • Stainless Steel Stents
    • Stomach Cancer

    By Mechanism

    • Balloon-Expandable Metal Stents (Bems)
    • Self-Expanding Metal Stents (Sems)

    By Coverage

    • Fully Covered Stents
    • Partially Covered Stents
    • Uncovered Stents

    By Application

    • Benign Strictures & Leaks
    • Biliary Disease
    • Biliary Diseases
    • Gastrointestinal Cancer
    • Other Applications

    By End User

    • Ambulatory Surgical Centers
    • Hospitals & Clinics
    • Specialty Endoscopy Centers/Gi Clinics

    EUROPE: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031

    Segment20242025202620272028202920302031CAGR (%)
    AMBULATORY SURGICAL CENTERS13.914.615.416.317.218.119.220.35.6
    HOSPITALS & CLINICS106.5111.2116.4121.8127.7133.9140.6147.84.9
    SPECIALTY ENDOSCOPY CENTERS/GI CLINICS34.135.937.94042.344.747.450.25.8
    TOTAL154.5161.8169.7178.1187.2196.8207.2218.35.2

    REST OF EUROPE: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031

    Segment20242025202620272028202920302031CAGR (%)
    AMBULATORY SURGICAL CENTERS1.531.61.671.741.821.9122.14.7
    HOSPITALS & CLINICS9.359.6710.0210.3910.7911.211.6512.123.9
    SPECIALTY ENDOSCOPY CENTERS/GI CLINICS3.013.153.293.443.613.783.964.164.8
    TOTAL13.8914.4214.9815.5816.2216.8917.6118.384.2

    Target Audience

    • Medical Device Manufacturers : Stent manufacturers and medical device companies need Europe-specific market data to optimize product portfolios, identify distribution partnerships, and allocate R&D resources across high-value European markets.
    • Healthcare Providers & Hospitals : European hospitals and gastroenterology centers require market insights to benchmark procurement strategies, evaluate supplier options, and plan capital investments in endoscopic stent capabilities.
    • Investment & Private Equity Firms : Investors targeting healthcare sectors need detailed European market analysis to assess acquisition opportunities, evaluate portfolio company growth potential, and identify emerging market consolidation trends.
    • Market Consultants & Analysts : Healthcare consultants and business analysts require granular Europe market data to support client strategy development, competitive benchmarking, and market entry planning across the region.
    • Regulatory & Compliance Professionals : Regulatory affairs specialists and compliance teams need Europe-specific market intelligence to understand regional requirements, reimbursement landscapes, and clinical adoption patterns for stent technologies.

    Key Companies in the Europe Gastrointestinal Stent Market

    CompanyHQOwnershipStrongest segments
    ATS AUTOMATION TOOLING SYSTEMS INCCanadaPublic CompanyCustom automated manufacturing and assembly systems,Pre- and post-automation services and lifecycle support,Contract manufacturing and integration services,
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (coronary, structural heart, CRM, peripheral),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention),MedSurg – Urology and Pelvic Health,
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions (endoscopes, devices, services),Surgical Endoscopes & Integrated OR Solutions,Advanced Energy Devices,
    M.I. TECHMalaysiaPublic CompanyDie sorting and smart binning equipment,Test handling and vision inspection equipment,Laser bonding and precision bonding equipment,
    MICRO-TECH (NANJING) CO., LTD.ChinaPublic CompanyDigestive endoscopy – ESD and ERCP (therapeutic devices and accessories),Stents and dilation/biopsy systems (biliary, intestinal, esophageal),Hemostasis, EUS, and diagnostic accessories,
    MERIT MEDICAL SYSTEMSUnited StatesPublic CompanyCardiovascular access and intervention (micropuncture, sheaths, guidewires, angiography, hemostasis),Peripheral intervention and embolotherapy (angiography, drainage, delivery, embolic solutions),Oncology and spine (soft tissue biopsy, vertebral augmentation, RF ablation, bone biopsy),
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio,
    STERISIrelandPublic CompanyHealthcare sterilization, decontamination, and OR infrastructure,Applied Sterilization Technologies (outsourced sterilization services),Life sciences contamination control and processing,
    BDUnited StatesPublic CompanyMedical Essentials (IV access, syringes, needles, sharps, vascular care),Connected Care (infusion systems, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
    Q3 MEDICAL GROUPIrelandPrivate CompanySpecialty procedures and interventions,Outpatient and ambulatory services,Diagnostics and imaging,
    BVMTunisiaPublic CompanyFire, miscellaneous accidents, and engineering,Marine, energy, and aviation (including pools),Agricultural and emerging risks,

    ATS AUTOMATION TOOLING SYSTEMS INC

    ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 that employs 7,000 people. The company specializes in automation and tooling systems.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. The company operates in the medical device and healthcare sectors.

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates across imaging, medical, and industrial technology sectors.

    M.I. TECH

    M.I. Tech is a Malaysian public company founded in 2007 with 594 employees. The company operates in the technology sector.

    MICRO-TECH (NANJING) CO., LTD.

    Micro-Tech (Nanjing) Co., Ltd. is a Chinese public company founded in 2000 with 2,433 employees. The company operates in the medical device industry.

    MERIT MEDICAL SYSTEMS

    Merit Medical Systems is a United States-based public company founded in 1987 with 7,500 employees. The company manufactures and distributes medical devices and supplies.

    MEDTRONIC

    Medtronic is an Ireland-based public company founded in 1949 with 95,000 employees. The company is a global leader in medical technology, services, and solutions.

    STERIS

    STERIS is an Ireland-based public company founded in 1985. The company provides sterilization and contamination control solutions for healthcare and industrial markets.

    BD

    BD is a United States-based public company founded in 1897 with 72,000 employees. The company is a global medical technology company specializing in medical devices, diagnostics, and biosciences.

    Q3 MEDICAL GROUP

    Q3 Medical Group is an Ireland-based private company founded in 2013. The company operates in the medical device or healthcare sector.

    BVM

    BVM is a Tunisia-based public company founded in 1981 with 99 employees. The company operates in the medical or industrial sector.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 318.6 Million · 5.5% wtd CAGR ·
    Asia Pacific
    ~USD 207.9 Million · 7.1% wtd CAGR ·
    Latin America
    ~USD 49.9 Million · 4.6% wtd CAGR ·
    Middle East & Africa
    ~USD 21.9 Million · 3.1% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    GermanyUSD 53.48 Million
    UKUSD 40.78 Million
    FranceUSD 36.37 Million
    ItalyUSD 27.95 Million
    SpainUSD 20.24 Million
    NetherlandsUSD 8.43 Million
    SwedenUSD 7.13 Million
    PolandUSD 5.55 Million
    Rest Of EuropeUSD 18.38 Million

    Country market size visualization

    Germany
    USD 53.48 Million
    UK
    USD 40.78 Million
    France
    USD 36.37 Million
    Italy
    USD 27.95 Million
    Spain
    USD 20.24 Million
    Netherlands
    USD 8.43 Million
    Sweden
    USD 7.13 Million
    Poland
    USD 5.55 Million
    Rest Of Europe
    USD 18.38 Million

    Reasons to Buy this Report

    • Country-Level Market Segmentation : Access detailed market sizing for 9 European countries including Germany (USD 53.48M), UK (USD 40.78M), and France (USD 36.37M), enabling precise market targeting and regional strategy development.
    • Competitive Landscape Intelligence : Understand market dynamics specific to Europe's mature healthcare environment, including reimbursement patterns, regulatory requirements, and competitive positioning of major stent manufacturers across the region.
    • Growth Opportunity Identification : Identify high-growth segments within Europe's 5.2% CAGR expansion, including emerging markets in Central and Eastern Europe and innovation opportunities in biliary and esophageal stent technologies.
    • Strategic Market Planning : Leverage Europe-specific forecasts through 2031 to develop targeted go-to-market strategies, partnership opportunities, and product development roadmaps aligned with regional healthcare trends and aging populations.
    • Regulatory and Reimbursement Insights : Gain comprehensive understanding of Europe's CE marking requirements, healthcare reimbursement frameworks, and clinical adoption drivers essential for successful market entry and expansion strategies.

    Frequently asked questions

    What is the current size of Europe's gastrointestinal stent market?

    Europe's gastrointestinal stent market is valued at USD 169.7 million in 2026 and is expected to grow to USD 218.3 million by 2031.

    What is the projected growth rate for Europe's gastrointestinal stent market?

    Europe's gastrointestinal stent market is projected to grow at a compound annual growth rate (CAGR) of 5.2% from 2026 to 2031.

    What factors are driving growth in Europe's gastrointestinal stent market?

    Key drivers include an aging population, rising prevalence of gastrointestinal disorders and cancers, technological innovations in stent design, and established healthcare reimbursement frameworks across Europe.

    Which stent types are most commonly used in Europe?

    Self-expanding metal stents (SEMS) and covered stents are increasingly adopted in Europe for both biliary and esophageal applications, particularly in palliative care settings.

    How does Europe's regulatory environment impact the gastrointestinal stent market?

    Europe's CE marking requirements and stringent regulatory standards ensure high product quality and safety, building clinical confidence and supporting market growth across the region.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the gastrointestinal stent market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the gastrointestinal stent market. Primary sources from the demand side include gastroenterologists, interventional endoscopists, and surgeons from hospitals and ambulatory surgical centers, as well as directors of endoscopy units and gastrointestinal clinics.

    A breakdown of the primary respondents is provided below:

    Gastrointestinal Stent Market Size, and Share

    Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

    Note 2: Other designations include sales, marketing, and product managers.

    Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the gastrointestinal stent market was determined through data triangulation using three approaches, as outlined below. After each approach, the weighted average of the three approaches was calculated based on the level of assumptions used in each.

    Gastrointestinal Stent Market : Top-Down and Bottom-Up Approach

    Gastrointestinal Stent Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed where applicable to complete the overall market engineering process and derive the exact statistics for all segments and subsegments.

    Market Definition

    The gastrointestinal stent market comprises medical devices designed for the minimally invasive management of obstructions, strictures, leaks, and fistulas within the gastrointestinal tract, including the esophagus, stomach, intestines, and biliary system. These stents, primarily self-expanding metal, plastic, and biodegradable variants, are deployed endoscopically or fluoroscopically to restore luminal patency, enable fluid drainage, and support tissue healing in both malignant and benign conditions. The market includes products, delivery systems, and associated technologies used across hospitals, ambulatory surgical centers, and specialty clinics, with applications spanning oncology, post-surgical complications, and chronic gastrointestinal disorders, driven by the growing preference for minimally invasive treatment approaches and improved patient outcomes.

    Key Stakeholders

    • GI stent manufacturers (metal, plastic, biodegradable stents)
    • Endoscopy device & delivery system manufacturers
    • Raw material & component suppliers (metals, polymers, coatings)
    • Hospitals & ambulatory surgical centers (public & private)
    • Gastroenterology clinics & endoscopy centers
    • Gastroenterologists, interventional endoscopists & GI surgeons
    • Contract manufacturers & OEM partners
    • Distributors & regional channel partners
    • Academic & clinical research institutions
    • Regulatory authorities & healthcare agencies
    • Market research & consulting firms
    • Investors & private equity firms

    Report Objectives

    • To define, describe, segment, and forecast the gastrointestinal stent market by product, type, application, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall gastrointestinal stent market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the gastrointestinal stent market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the gastrointestinal stent market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Customization Options:

    With the market data provided, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

    Company Information

    • Detailed analysis and profiling of additional market players (up to 5)

    Geographic Analysis

    • Further breakdown of the Rest of Europe gastrointestinal stent market into Austria, Finland, Switzerland, and other countries
    • Further breakdown of the Rest of Latin America gastrointestinal stent market into Colombia, Chile, and other countries

    Competitive Landscape Assessment

    • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the gastrointestinal stent market
    • Competitive leadership mapping for established players in the US

    Get the Full Gastrointestinal Stent Market Report

    Full forecast, segment splits, and company analysis for all Gastrointestinal Stent Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status